Aiming at introducing more academic and clinical guidance to pediatrics, Shanghai Johnson & Johnson Pharmaceuticals, Ltd. and Xian Janssen Pharmaceuticals, Ltd. held the 3rd “China’s Window on Pediatrics” via the Medical Education Academy of J&J China. This medical education activity was held in Shanghai and Beijing on March 28th and 29th.
The session in Shanghai was co-chaired by Prof. Sun Kun, President of Xin Hua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, and Prof. Lu Quan, Professor in the Respiratory Department of Children’s Hospital of Shanghai. The session in Beijing was co-chaired by Prof. Wang Tianyou, CPC Party Secretary of Beijing Children’s Hospital, Capital Medical University and Prof. Shen Kunling, Vice President of Beijing Children’s Hospital, Capital Medical University.
The 3rd “China’s Window on Pediatrics” expanded on three clinical topics: The Treatment and Safe Medication of Acute Fever in Children in Chinese & Western Medicine; Care & Treatment of Children’s Cough and GER; and Sharing Experience & Cases of Domestic & Overseas Diagnosis and Treatment of the Common Cold in Children.
The activity adopted the most advanced webcast technology to connect the two main venues in Shanghai and Beijing to ten other cities, with the network signal covering more than 30 cities overall. About 2,500 pediatricians took part. Additionally the technology allowed more pediatricians to watch via computer, mobile phone, iPad, and other devices.
Dr. Li Qing, Senior Director of ONE China OTC Medical Affairs & Medical Education, introduced one important innovation from this year’s event: “We introduced ‘Experts’ Conversation’ into the conference. In other words, we invited two experts to share their opinions from different therapeutic areas for the same topic, in order to introduce new models for pediatric academic exchange.”
A new WeChat platform was also used in the conference. It facilitated real-time interaction between the experts and participants nationwide, with questions answered directly by mobile phone. The platform facilitated the sharing of medical knowledge and valuable expert experience to even more pediatricians in all areas of China, prompting both medical experts and clinical pediatricians alike to express their appreciation of the innovative communications used at the forum.
Professor Lu Quan from Children’s Hospital of Shanghai said that: “The health of children is closely linked with the development of our country and society, and we pediatricians bear the honorable mission of protecting children’s health. ‘China’s Window on Pediatrics’ provides a platform for pediatricians to study and exchange ideas, especially for those grass-roots pediatricians in China; it has therefore contributed a lot to improving clinical performance among medical workers.”
James Li, Vice President, ONE China OTC, commented that “We hope to encourage more pediatricians to gather together to learn and share with each other through this program. SJJP and XJP will stand by Chinese pediatricians to help more children and safeguard their healthy growth by propelling ‘China’s Window on Pediatrics’ further afield every year.”
About “China’s Window on Pediatrics”
In 2013, Shanghai Johnson & Johnson Pharmaceuticals, Ltd. held the first “China’s Window on Pediatrics” conference. The program is intended “to share clinical cases, discuss practices, and to standardize diagnosis and treatment.” It invites pediatric experts in fever, cold, cough and digestion in China to interpret guidelines, share practical cases and promote safe use of medication. It also provides pediatricians with clinical instruction based in the latest medical academic development. “China’s Window on Pediatrics” together with the “World Window on Pediatrics” reflects the commitment of Shanghai Johnson & Johnson Pharmaceuticals, Ltd. and Xian Janssen Pharmaceuticals, Ltd. to caring for society and our aspiration to drive clinical and academic development in pediatrics.
